Avandia diabetes drug

Avandia diabetes drug

C007/2561 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.3MB

Downloadable file size: 1.6MB

Price image Pricing

Please login to use the price calculator


Credit: MARK THOMAS/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only

Caption: Avandia diabetes drug packaging and tablets. This drug belongs to a group of drugs known as thiazolidinediones that are used to treat type II diabetes. It controls blood sugar levels by reducing the production and secretion of glucose by the liver and increasing the body's sensitivity to insulin, the hormone that regulates blood glucose levels. Avandia requires that some insulin is produced by the pancreas and so cannot be used to treat type I diabetes. Avandia has been recommended for withdrawal in the UK due to a link to an increased risk of heart attacks and heart failure.

Release details: Model release not required. Property release not available.

Keywords: 4 milligrams, 4mg, anti-diabetic, antihyperglycemic agent, avandia, blood glucose level, blood sugar level, box, dangerous, diabetes, drug, glaxosmithkline, gsk, heart attack, heart failure, insulin sensitiser, medical, medicine, packaging, packet, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, rosiglitazone, still life, still-life, tablet, tablets, thiazolidinedione, treatment, type 2, type ii

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.